Camp4 Therapeutics Corporation · NASDAQ:CAMP

Enavate Sciences Gp, LLC reported a 4.80% stake in Camp4 Therapeutics Corporation (Schedule 13D/A)

Event Mar 9, 2026 · Filed Mar 11, 2026

Enavate Sciences Gp, LLC reported a 4.80% stake in Camp4 Therapeutics Corporation, 2,495,562 shares, with active intent on Mar 9, 2026. Filed Mar 11, 2026 (Schedule 13D/A).

Stake
4.80%
Shares
2,495,562
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Enavate Sciences GP, LLC4.80%2,495,562
Everest Aggregator, LP4.80%2,495,562

Source

View original at SEC

Related